Registered office moved from Asse to Mollem18-11Dividend €487,276Equity from €243,015 to €3,000Debts from €40,166 to €279,056Cash from €140,100 to €196,482
Lower solvency than 94% of companies in human health. The sector median is 63.1%, over 21,373 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as Dr. Kjell Van Royen has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Micro
5 to 10 years old
solvency under 10%
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for Dr. Kjell Van Royen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Registered office moved from Asse to Mollem
The registered office moved from Mollemseweg 35, 1730 Asse to Winkelbaan 36, 1730 Mollem · General meeting of 21-10-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0760428629
Registered office moved from Bruges to Asse
The registered office moved from Kervyndreef 38, 8200 Brugge to Mollemseweg 35, 1730 Asse · Board meeting of 10-08-2023 · Gazette deed
Incorporation
Founded by Name after signing inVisible after signing in · 300 shares · Name hiddenVisible after signing in appointed as director · published on 24-12-2020 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Dr. Kjell Van Royen: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €263,000 and €297,000, founded between 2020 and 2021.
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Kjell Van Royen?
Dr. Kjell Van Royen is a private limited company (BV).
When was Dr. Kjell Van Royen founded?
Dr. Kjell Van Royen was founded on 22-12-2020.
Is Dr. Kjell Van Royen still active?
Yes, Dr. Kjell Van Royen is an active enterprise in the KBO register.
What is the turnover of Dr. Kjell Van Royen?
The turnover in financial year 2025 is about €510,000. This figure is estimated from the gross margin of €338,069 and 31 comparable companies (NACE 86220). It probably lies between €450,000 and €710,000.Financials
Is Dr. Kjell Van Royen profitable?
In financial year 2025, Dr. Kjell Van Royen made a profit of €247,261.
Where can I find the annual accounts of Dr. Kjell Van Royen?
Dr. Kjell Van Royen filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Kjell Van Royen due?
Dr. Kjell Van Royen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline